)
)
NeurAxis Investor Relations Material
Latest events
Q3 2024
NeurAxis
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from NeurAxis Inc
Access all reports
NeurAxis, Inc. is a medical technology company specializing in neuromodulation therapies aimed at addressing chronic and debilitating conditions in both children and adults. The company’s primary product, IB-Stim, utilizes Percutaneous Electrical Nerve Field Stimulation (PENFS) technology to alleviate functional abdominal pain associated with irritable bowel syndrome (IBS) in patients aged 11 to 18. The company is headquartered in Carmel, Indiana, and its shares are listed on the NYSE American.
Key slides for NeurAxis Inc
Q3 2024
NeurAxis Inc
Q3 2024
NeurAxis Inc
Latest articles
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
)
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
NRXS
Country
🇺🇸 United States